fbpx
Home > Blog > Seventeen Minutes of Science: Using C. elegans to model neurodegenerative diseases

Seventeen Minutes of Science: Using C. elegans to model neurodegenerative diseases

Tune in weekly to our virtual series “Seventeen Minutes of Science” every Tuesday at 11am PST / 2pm ET where we go live on Facebook with a new guest each week to talk about how science and biotechnology is woven into their lives for (you guessed it) 17 minutes!

For episode 40 of 17 Minutes of Science we are joined by Dr. Anne Hart, a neuroscience professor and Chair of Neuroscience at Brown University.

Dr. Anne Hart obtained her Ph.D. in Neuroscience at UCLA with Dr. S.L. Zipursky working on cell fate specification in the Drosophila eye. She undertook her post-doctoral training in C. elegans genetics with Dr. Josh Kaplan in the Department of Molecular Biology at Massachusetts General Hospital. Dr. Hart joined the Center for Cancer Research at the Massachusetts General Hospital and the Harvard Medical School Department of Pathology as an assistant professor and taught numerous classes in genetics and neuroscience. She moved to the Department of Neuroscience at Brown University in the fall of 2009. She has served as faculty in neuroscience courses at the Marine Biological Laboratories and the Okinawa Institute of Science and Technology. Currently, she is the Speaker for the MBL Society. Her research focuses on the molecular and cellular mechanisms underlying neurological disease, sensory signaling, sleep, and fatigue.

Dr. Hart will be joining us to discuss her research using C. elegans which focuses on the molecular and cellular mechanisms underlying neurological disease, sensory signaling, sleep, and fatigue.

About The Author

InVivo Biosystems

InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts. An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging and other disease studies. In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly in early-stage development of new compounds.

Share this articles

Facebook
Twitter
Pinterest
LinkedIn
InVivo Biosystems

About the Author:

Connect with us